Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
ABOUT THIS PAGE
37
PharmaCompass offers a list of Suvecaltamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Suvecaltamide manufacturer or Suvecaltamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Suvecaltamide manufacturer or Suvecaltamide supplier.
PharmaCompass also assists you with knowing the Suvecaltamide API Price utilized in the formulation of products. Suvecaltamide API Price is not always fixed or binding as the Suvecaltamide Price is obtained through a variety of data sources. The Suvecaltamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide, including repackagers and relabelers. The FDA regulates 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide supplier is an individual or a company that provides 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide active pharmaceutical ingredient (API) or 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide finished formulations upon request. The 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide suppliers may include 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide API manufacturers, exporters, distributors and traders.
2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide GMP manufacturer or 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide GMP API supplier for your needs.
A 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide CoA (Certificate of Analysis) is a formal document that attests to 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide's compliance with 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide specifications and serves as a tool for batch-level quality control.
2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide CoA mostly includes findings from lab analyses of a specific batch. For each 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide may be tested according to a variety of international standards, such as European Pharmacopoeia (2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide EP), 2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide USP).
